Diabetes complications

Differential associations of risk factors with severe and non‐severe hypoglycaemia: the Hypoglycaemia Assessment Tool prospective observational study in people with insulin‐treated type 1 diabetes and type 2 diabetes

Diabetes Obes MetabPublished Prospective observational study

Authors' conclusion

The risk of severe versus non-severe hypoglycaemia differs in patients with T1D and T2D; sex, the use of a CGM and insulin pump, and geographical areas were differently associated with one type of hypoglycaemia than the other.

Study context

Population
Patients with insulin-treated T1D and T2D in 24 countries
Participants
5,949 vs 12,914
Exposure
Risk factors for severe vs non-severe hypoglycaemia
  • T1Dn = 5,949
  • T2Dn = 12,914
Outcome
Differential association of risk factors with severe and non-severe hypoglycaemia
Follow-up
4 weeks
Methodological details24 countries, 4-week period
  • 24 countries
  • 4-week period

Main finding

As reported in the abstract

Differential excess risk of severe vs non-severe hypoglycaemia by risk factor

Excess risk higher for severe than non-severe hypoglycaemia in females vs males with T2D

42%

Excess risk higher for severe than non-severe hypoglycaemia in T2D with vs without continuous glucose monitoring (CGM)

27%

Excess risk lower for severe than non-severe hypoglycaemia in T1D with vs without insulin pump

47%

Observational data: associations, not effects.

Further findings

4-week rate of non-severe hypoglycaemia (episodes per person)

Median age

OutcomeT1DT2D
4-week rate of severe hypoglycaemia0.940.30

Original publication

Differential associations of risk factors with severe and non‐severe hypoglycaemia: the Hypoglycaemia Assessment Tool prospective observational study in people with insulin‐treated type 1 diabetes and type 2 diabetes. Diabetes Obes Metab. Published 3 June 2024. doi:10.1111/dom.15677

Composed by AI from the published abstract and checked against it. How Briefs are made →

Get them every week

New studies on this topic in My Week and in your Monday e-mail.

We e-mail you a sign-in link and a code. No password, no spam.